Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Oxygen Biotherapeutics has entered into a research pact with Hackensack University Medical Center (HUMC) so as to research wound healing properties of the Oxygen Biotherapeutics' Wundecyte perfluorocarbon (PFC) and its new oxygen-producing bandage for treatment of full-thickness excisional wounds and partial thickness burns.
Subscribe to our email newsletter
Both the parties said that a research scientist at HUMC, Antoine Carlisle, will be the principal investigator for this research.
Oxygen Biotherapeutics chief medical officer Gerald Klein said they believe that providing additional oxygen may help heal wounds, fight infections and decrease scarring.
"Wundecyte, our PFC gel, used alone and in combination with a bandage that releases oxygen to the damaged tissue site, may be particularly useful in military applications," Klein said.
"Naturally, if study results are favorable, it may also have applications for civilian injuries as well."